Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04924621
Other study ID # PKUSSIRB-202163045
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 10, 2021
Est. completion date June 10, 2022

Study information

Verified date April 2022
Source Peking University
Contact Xudong Yang, MD
Phone 62179977
Email kqyangxudong@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To compare the difference in endotracheal intubation in participants with difficult airway between under general anesthesia by Transnasal Humidified Rapid-Insufflation Ventilatory Exchange and under traditional sedation by mask ventilation. The investigators focus on the different outcomes in oxygenation maintaince, carbon dioxide removal and the effectiveness of safety apnea time, to evaluate the safety of receiving endotracheal intubation under general anesthesia in participants with difficult airway.


Recruitment information / eligibility

Status Recruiting
Enrollment 42
Est. completion date June 10, 2022
Est. primary completion date May 10, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria - Age 18-60 - Patients with difficult airway assessed by two anesthesiologists according to the difficult airway score who needed to undergo nasal endotracheal intubation for oral and maxillofacial surgery in Peking University Stomatological Hospital. - BMI between 18 to 30 kg/m2 - ASA Grade I to II - NYHA grade I - Patients requiring arterial hemodynamics monitoring and blood gas analysis due to surgical requirements - Signed the informed consent Exclusion Criteria - Respiratory diseases: respiratory failure, COPD, pulmonary fibrosis, asthma and other diseases. Patients with ventilatory dysfunction or airway obstruction. - NYHA cardiac function grade greater than I, or NYHA cardiac function grade I but with a history of coronary heart disease. - Conditions affecting the monitoring of peripheral oxygen saturation, such as poor peripheral circulation perfusion and application of vasoconstrictor, are present. - Indoor oxygen saturation below 92%. - Patients who cannot tolerate rapid exchange ventilation with nasal humidification. - Patients with a history of easy nasal bleeding. - Inability to understand or express pain scores. - Menstrual period and lactation period of female patients. - The patient has mental illness. - Patients with severe intraoperative complications should be removed after surgery

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Respiratory Humidification Treatment Device, AIRVO 2 PT101AZ, Fisher & Paykel Healthcare, Inc.
The nasal cavity was disinfected with Iodophor cotton swab, and the appropriate nasal cavity was selected for endotracheal intubation assisted by fiberoptic bronchoscope according to the experience of anesthesiologists. After the endotracheal intubation was fixed, the anesthesia machine was connected for mechanical ventilation. The anesthesia machine was set at 50% oxygen +50% air, and the tidal volume was set at 6-8ml/kg.
Mask ventilation
The Control Group will receive sequential intravenous infusion of Sufentanil 5ug, midazolam 0.05mg/kg, and propofol 1-2ug/ml, to make the BIS between 70 and 80. 2ml tetracaine was injected with cyclothyroid membrane puncture, and the nasal cavity was disinfected with iodophor cotton swab. According to the experience of anesthesiologists, the appropriate nasal cavity was selected for intranasal endotracheal intubation assisted by fiberbronchoscope. After the endotracheal intubation was successful, the anesthesia machine was connected for mechanical ventilation, full narcotic inducer will be injected. The anesthesia machine was set at 50% oxygen +50% air, and the tidal volume was set at 6-8ml/kg.
Drug:
Midazolam(T group)
Midazolam 0.05mg/kg, intravenous injection
Sufentani(T group)
Sufentanil 0.02-0.05ug/kg, intravenous injection
Propofol(T group)
Propofol 2-3ug/ml, intravenous injection
Rocuronium(T group)
Rocuronium 0.06mg/kg, intravenous injection
Drug use target(T group)
Make BIS < 60 .
Sufentanil(C group)
Sufentanil 5ug, intravenous injection
Midazolam(C group)
Midazolam 0.05mg/kg, intravenous injection
Propofol
Propofol 1-2ug/ml, intravenous injection
Tetracaine(C group)
2ml tetracaine was injected with cyclothyroid membrane puncture.
Drug use target
Make the BIS between 70 and 80.

Locations

Country Name City State
China Peking University Hospital of Stomatology Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Peking University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood oxygen pressure Blood oxygen pressure after intubation immediately. Day 0
Primary Pulse oxygen saturation Pulse oxygen saturation after intubation immediately. Day 0
Primary Blood carbon dioxide pressure Blood carbon dioxide pressure after intubation immediately. Day 0
Secondary Endtidal CO2 Endtidal CO2 at time point of TA?TB?TC?TD Day 0
Secondary Success of intubation Proportion of successful endotracheal intubation Day 0
Secondary Arrhythmias or dramatic haemodynamic fluctuations Arrhythmias and dramatic fluctuations in heart rate and blood pressure: types and times of arrhythmias in the test were recorded. Changes in heart rate and blood pressure more than 30% before surgery were recorded as dramatic fluctuations. Day 0
Secondary Tolerance of intubation The score of patient's tolerance to endotracheal intubation one day after surgery (0-10 points, 0 point is completely intolerable, 10 point is completely intolerable) Day 1
Secondary Time to complete intubation Time required to complete endotracheal intubation Day 0
Secondary SPO2 below 95% Percentage of patients with pulse oxygen saturation below 95% during the trial Day 0
Secondary SPO2 below 92% Percentage of patients with pulse oxygen saturation below 92% during the trial Day 0
See also
  Status Clinical Trial Phase
Completed NCT01823328 - Ketamine Versus Etomidate for Rapid Sequence Intubation Phase 4
Completed NCT01765530 - Efficacy Study of a Novel Device to Clean the Endotracheal Tube N/A
Withdrawn NCT01634867 - Observational Study of Rapid Sequence Intubation (RSI) Drug Delivery Using Intraosseous (IO) and Intravenous (IV) Access in Pediatric Patients N/A
Withdrawn NCT04258215 - PSA (Pharachute Supralaryngeal Airway) for Positive Pressure Ventilation (PPV) N/A
Recruiting NCT04080440 - Brain-injured Patients Extubation Readiness Study N/A
Terminated NCT01486407 - Observational Study of Rapid Sequence Intubation (RSI) Drug Delivery Using Intraosseous (IO) and Intravenous (IV) Access. N/A
Recruiting NCT04100564 - LITES Task Order 0005 Prehospital Airway Control Trial (PACT) N/A